Cost-benefit analysis of 3D conformal radiation therapy: Treatment of prostate cancer as a model

Acta Oncologica

Volumn 38, Issue 5, 1999, Pages 603-612

  Cho, Kwan H ^a   Khan, Faiz M ^a   Levitt, Seymour H ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; COST BENEFIT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RISK; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0032865674     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431195     Document Type: Article

References (20)

1. 1. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements, 1993.
2. 2. Purdy JA. Defining our goals: volume and dose specification for 3-D conformal radiation therapy. In: Meyer JL, Purdy JA, eds. 3-D conformal radiotherapy. Basel: Karger, Front Radiat Ther Oncol 1996; 29: 24-30.
3. 3. Huch Boni RA, Boner JA, Debatin JF, et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 1995; 50: 593-600.
4. 4. Bates TS, Gillatt DA, Cavanagh PM, Speakman M. A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br J Urol 1997; 79: 927-32.
5. 5. Tarean T, Turkeri L, Biren T, Kullo S, Gurmen N, Akdas A. The effectiveness of imaging modalities in clinical staging of localized prostatic carcinoma. Int Urol Nephrol 1996; 28: 773-9.
6. 6. Roach M III, Faillace-Akazawa P, Malfatti C, Holland J, Bricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996; 35: 1011-8.
7. 7. Logue JP, Sharrock CL, Cowan RA, Read G, Marrs J, Mott D. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 1998; 41: 929-31.
8. 8. Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33: 1321-9.
9. 9. Verhey LJ. Immobilizing and positioning patients for radiotherapy. Semin Radiat Oncol 1995; 5: 100-14.
10. 10. Lyman JT. Normal tissue complication probabilities: variable dose per fraction. Int J Radiat Oncol Biol Phys 1991; 22: 247-50.
11. 11. Hanks GE, Hanton AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501-10.
12. 12. Zelefsy MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491-500.
13. 13. Fukunaga-Johnson N, Sandler HM, McLaughlin PW, et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 311-7.
14. 14. Pollack A, Zagars GK, Starkschall G, et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 1996; 34: 555-64.
15. 15. Asbell SO, Krall JM, Pilepich MV, et al. Elective pelvic irradiation in Stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. Int J Radiat Oncol Biol Phys 1988; 15: 1307-16.
16. 16. Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991; 21: 935-.
17. 17. Hanlon AL, Schultheiss TE, Hunt MA, Movsas B, Peter RS, Hanks GE. Chronic rectal bleeding after high dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys 1997; 38: 59-63.
18. 18. Cho KH, Lee CKK, Levitt SH. Proctitis after conventional external radiation therapy for prostate cancer: Importance of minimizing posterior rectal dose. Radiology 1995; 195: 699-703.
19. 19. Pollack A, Zagars GK. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 1011-8.
20. 20. Corn BW, Hanks GE, Schultheiss TE, Hunt MA, Lee WR, Coia LR. Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys 1995; 32: 325-30.